Search
ImmuCell Corp
ICCCAdd to Watchlist
10.290USD
-0.710-6.45%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
93.09MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-02 The current financial score of ImmuCell Corp is 9.01, ranking 18 out of 157 in the Pharmaceuticals industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 10.36M, representing a year-over-year increase of 28.39%, while its net profit experienced a year-over-year increase of 34.18%.
Financials
7.97
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
9.24
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
10.00
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
10.00
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.83
Free cash flow
Relevant data have not been disclosed by the company yet.